These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12416332)

  • 21. Medical equipment: Netherlands.
    Surg Bus; 1978 Mar; 41(3):38-40, 86. PubMed ID: 10307142
    [No Abstract]   [Full Text] [Related]  

  • 22. [Yield calculation of an item of capital expenditure].
    Seewer M
    Schweiz Arch Tierheilkd; 2011 Aug; 153(8):382-3. PubMed ID: 21780068
    [No Abstract]   [Full Text] [Related]  

  • 23. Italy: a performance review.
    Galavotti P
    Med Device Technol; 2003 Jun; 14(5):32-3. PubMed ID: 12852121
    [No Abstract]   [Full Text] [Related]  

  • 24. Boston Scientific scores. Dollar 27 billion dealfor Guidant moves it into new sector.
    Becker C
    Mod Healthc; 2006 Jan; 36(5):17. PubMed ID: 16479778
    [No Abstract]   [Full Text] [Related]  

  • 25. Editorial: Biotech in the financial crisis.
    Jungbauer A
    Biotechnol J; 2009 Aug; 4(8):1095. PubMed ID: 19685457
    [No Abstract]   [Full Text] [Related]  

  • 26. Executive compensation at private biotech companies: a competitive environment.
    Rychlik B; Dipierro M
    Nat Biotechnol; 2008 Jan; 26(1):133-4. PubMed ID: 18183026
    [No Abstract]   [Full Text] [Related]  

  • 27. Denmark high spending.
    Med Device Technol; 1999 Dec; 10(10):70-1. PubMed ID: 10788272
    [No Abstract]   [Full Text] [Related]  

  • 28. Selecting medical devices and materials for development in Korea: the analytic hierarchy process approach.
    Cho KT; Kim SM
    Int J Health Plann Manage; 2003; 18(2):161-74. PubMed ID: 12841155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Public biotechnology 2003-the numbers.
    Lähteenmäki R; Baker M
    Nat Biotechnol; 2004 Jun; 22(6):665-70. PubMed ID: 15175683
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of the industry sponsor: protection of human subjects in early device-application studies.
    Oleson KA
    J Lab Clin Med; 2005 Jan; 145(1):17-20. PubMed ID: 15668657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Business opportunities abound in Israel.
    Nir MM; Rotem-Bar J
    Med Device Technol; 2002 Oct; 13(8):43-4. PubMed ID: 12416334
    [No Abstract]   [Full Text] [Related]  

  • 32. Device deals dominate. DJO, Biomet buyouts gain steam as Abbott's fizzles.
    Rhea S
    Mod Healthc; 2007 Jul; 37(29):17. PubMed ID: 17844789
    [No Abstract]   [Full Text] [Related]  

  • 33. Betting against the SEC--and winning.
    Clifford L
    Fortune; 2002 May; 145(10):170. PubMed ID: 12025350
    [No Abstract]   [Full Text] [Related]  

  • 34. Medical devices in the UK: a healthy industry.
    Med Device Technol; 1998 Mar; 9(2):52-4. PubMed ID: 10186978
    [No Abstract]   [Full Text] [Related]  

  • 35. Supply executives predict a better 2003.
    Hosp Mater Manage; 2003 Feb; 28(2):15. PubMed ID: 12602180
    [No Abstract]   [Full Text] [Related]  

  • 36. [Market economy, health economy?].
    De Wever A
    Rev Med Brux; 2002 Sep; 23(4):A227-30. PubMed ID: 12422439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Denmark in focus.
    Med Device Technol; 2004; 15(1):74. PubMed ID: 14994640
    [No Abstract]   [Full Text] [Related]  

  • 38. Differential effects of public and private funding in the medical device industry.
    Kang HD; Edelman ER; Ku DN
    Expert Rev Med Devices; 2018 Feb; 15(2):91-98. PubMed ID: 29256320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid medical advances challenge the tooling industry.
    Conley B
    Med Device Technol; 2008; 19(3):32-3. PubMed ID: 18557407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. France cutting costs. Espicom Ltd.
    Med Device Technol; 1999 Dec; 10(10):59, 62. PubMed ID: 10788268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.